No abstract available
MeSH terms
-
Anticarcinogenic Agents / therapeutic use*
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / metabolism
-
Carcinoma, Hepatocellular / diagnosis
-
Carcinoma, Hepatocellular / epidemiology
-
Carcinoma, Hepatocellular / genetics
-
Carcinoma, Hepatocellular / metabolism
-
Carcinoma, Hepatocellular / prevention & control*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Incidence
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / epidemiology
-
Liver Neoplasms / genetics
-
Liver Neoplasms / metabolism
-
Liver Neoplasms / prevention & control*
-
Patient Selection
-
Prognosis
-
Risk Assessment
-
Risk Factors
Substances
-
Anticarcinogenic Agents
-
Biomarkers, Tumor
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors